These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1047 related articles for article (PubMed ID: 27567465)

  • 1. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.
    Kirchhof P; Benussi S; Kotecha D; Ahlsson A; Atar D; Casadei B; Castella M; Diener HC; Heidbuchel H; Hendriks J; Hindricks G; Manolis AS; Oldgren J; Popescu BA; Schotten U; Van Putte B; Vardas P; Agewall S; Camm J; Baron Esquivias G; Budts W; Carerj S; Casselman F; Coca A; De Caterina R; Deftereos S; Dobrev D; Ferro JM; Filippatos G; Fitzsimons D; Gorenek B; Guenoun M; Hohnloser SH; Kolh P; Lip GY; Manolis A; McMurray J; Ponikowski P; Rosenhek R; Ruschitzka F; Savelieva I; Sharma S; Suwalski P; Tamargo JL; Taylor CJ; Van Gelder IC; Voors AA; Windecker S; Zamorano JL; Zeppenfeld K
    Europace; 2016 Nov; 18(11):1609-1678. PubMed ID: 27567465
    [No Abstract]   [Full Text] [Related]  

  • 2. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.
    Kirchhof P; Benussi S; Kotecha D; Ahlsson A; Atar D; Casadei B; Castella M; Diener HC; Heidbuchel H; Hendriks J; Hindricks G; Manolis AS; Oldgren J; Popescu BA; Schotten U; Van Putte B; Vardas P; Agewall S; Camm J; Baron Esquivias G; Budts W; Carerj S; Casselman F; Coca A; De Caterina R; Deftereos S; Dobrev D; Ferro JM; Filippatos G; Fitzsimons D; Gorenek B; Guenoun M; Hohnloser SH; Kolh P; Lip GY; Manolis A; McMurray J; Ponikowski P; Rosenhek R; Ruschitzka F; Savelieva I; Sharma S; Suwalski P; Tamargo JL; Taylor CJ; Van Gelder IC; Voors AA; Windecker S; Zamorano JL; Zeppenfeld K
    Eur J Cardiothorac Surg; 2016 Nov; 50(5):e1-e88. PubMed ID: 27663299
    [No Abstract]   [Full Text] [Related]  

  • 3. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.
    Kirchhof P; Benussi S; Kotecha D; Ahlsson A; Atar D; Casadei B; Castella M; Diener HC; Heidbuchel H; Hendriks J; Hindricks G; Manolis AS; Oldgren J; Popescu BA; Schotten U; Van Putte B; Vardas P;
    Eur Heart J; 2016 Oct; 37(38):2893-2962. PubMed ID: 27567408
    [No Abstract]   [Full Text] [Related]  

  • 4. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.
    Hindricks G; Potpara T; Dagres N; Arbelo E; Bax JJ; Blomström-Lundqvist C; Boriani G; Castella M; Dan GA; Dilaveris PE; Fauchier L; Filippatos G; Kalman JM; La Meir M; Lane DA; Lebeau JP; Lettino M; Lip GYH; Pinto FJ; Thomas GN; Valgimigli M; Van Gelder IC; Van Putte BP; Watkins CL;
    Eur Heart J; 2021 Feb; 42(5):373-498. PubMed ID: 32860505
    [No Abstract]   [Full Text] [Related]  

  • 5. [ESC guidelines on atrial fibrillation 2016 : Summary of the most relevant recommendations and modifications].
    Eckardt L; Häusler KG; Ravens U; Borggrefe M; Kirchhof P
    Herz; 2016 Dec; 41(8):677-683. PubMed ID: 27847992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [2020 ESC guidelines on atrial fibrillation : Summary of the most relevant recommendations and innovations].
    Sepehri Shamloo A; Dagres N; Hindricks G
    Herz; 2021 Feb; 46(1):28-37. PubMed ID: 33289046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of atrial fibrillation in patients with chronic kidney disease in Europe Results of the European Heart Rhythm Association Survey.
    Potpara TS; Lenarczyk R; Larsen TB; Deharo JC; Chen J; Dagres N;
    Europace; 2015 Dec; 17(12):1862-7. PubMed ID: 26733617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
    Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contemporary Atrial Fibrillation Management: A Comparison of the Current AHA/ACC/HRS, CCS, and ESC Guidelines.
    Andrade JG; Macle L; Nattel S; Verma A; Cairns J
    Can J Cardiol; 2017 Aug; 33(8):965-976. PubMed ID: 28754397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation.
    Chiang CE; Wu TJ; Ueng KC; Chao TF; Chang KC; Wang CC; Lin YJ; Yin WH; Kuo JY; Lin WS; Tsai CT; Liu YB; Lee KT; Lin LJ; Lin LY; Wang KL; Chen YJ; Chen MC; Cheng CC; Wen MS; Chen WJ; Chen JH; Lai WT; Chiou CW; Lin JL; Yeh SJ; Chen SA
    J Formos Med Assoc; 2016 Nov; 115(11):893-952. PubMed ID: 27890386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale and design of AXAFA-AFNET 5: an investigator-initiated, randomized, open, blinded outcome assessment, multi-centre trial to comparing continuous apixaban to vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation.
    Di Biase L; Callans D; Hæusler KG; Hindricks G; Al-Khalidi H; Mont L; Cosedis Nielsen J; Piccini JP; Schotten U; Kirchhof P
    Europace; 2017 Jan; 19(1):132-138. PubMed ID: 28130378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial fibrillation: stroke prevention in focus.
    Ferguson C; Inglis SC; Newton PJ; Middleton S; Macdonald PS; Davidson PM
    Aust Crit Care; 2014 May; 27(2):92-8. PubMed ID: 24054541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preference for oral anticoagulation therapy for patients with atrial fibrillation in Europe in different clinical situations: results of the European Heart Rhythm Association Survey.
    Larsen TB; Potpara T; Dagres N; Proclemer A; Sciarrafia E; Blomström-Lundqvist C;
    Europace; 2015 May; 17(5):819-24. PubMed ID: 25926476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polish and European management strategies in patients with atrial fibrillation. Data from the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot).
    Lenarczyk R; Mitręga K; Mazurek M; Janion M; Opolski G; Drożdż J; Streb W; Fuglewicz A; Sokal A; Laroche C; Lip GY; Kalarus Z
    Pol Arch Med Wewn; 2016; 126(3):138-48. PubMed ID: 27000745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stroke and thromboembolism prevention in atrial fibrillation.
    Jame S; Barnes G
    Heart; 2020 Jan; 106(1):10-17. PubMed ID: 31533990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry).
    Lip GY; Laroche C; Ioachim PM; Rasmussen LH; Vitali-Serdoz L; Petrescu L; Darabantiu D; Crijns HJ; Kirchhof P; Vardas P; Tavazzi L; Maggioni AP; Boriani G
    Eur Heart J; 2014 Dec; 35(47):3365-76. PubMed ID: 25176940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How are patients with atrial fibrillation approached and informed about their risk profile and available therapies in Europe? Results of the European Heart Rhythm Association Survey.
    Potpara TS; Pison L; Larsen TB; Estner H; Madrid A; Blomström-Lundqvist C;
    Europace; 2015 Mar; 17(3):468-72. PubMed ID: 25722478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation.
    Ramlawi B; Abu Saleh WK; Edgerton J
    Methodist Debakey Cardiovasc J; 2015; 11(2):100-3. PubMed ID: 26306127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Intraprocedural Anticoagulation in Patients on Non-Vitamin K Antagonist Oral Anticoagulants Undergoing Catheter Ablation for Atrial Fibrillation: Understanding the Gaps in Evidence.
    Martin AC; Godier A; Narayanan K; Smadja DM; Marijon E
    Circulation; 2018 Aug; 138(6):627-633. PubMed ID: 30354610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.